Compared to small-molecule drugs, antibodies are more effective and have fewer side effects, making them one of the most successful candidates for new drug development. Monoclonal antibodies (mAbs) are an important biologic agent that are immune system proteins created in the laboratory. Antibody Drug Development Services https://cmc.bocsci.com/biologics/antibody-drug-development.html